Overview
Stephanie Becker-Koepke is a Hematologist Oncology specialist and a Hematologist in Fenton, Missouri. Dr. Becker-Koepke is rated as an Experienced provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Colorectal Cancer, Lung Cancer, Pleuropulmonary Blastoma, and Familial Colorectal Cancer. Dr. Becker-Koepke is currently accepting new patients.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1011 Bowles Ave, Suite G50, Fenton, MO 63026
Washington University
Ramaswamy Govindan is an Oncologist in Saint Louis, Missouri. Dr. Govindan is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Govindan is currently accepting new patients.
Washington University
Daniel Morgensztern is an Oncologist in Saint Louis, Missouri. Dr. Morgensztern is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Morgensztern is currently accepting new patients.
Washington University
Saiama Waqar is an Oncologist in Saint Louis, Missouri. Dr. Waqar is rated as an Elite provider by MediFind in the treatment of Non-Small Cell Lung Cancer (NSCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma. Dr. Waqar is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Becker-Koepke isAdvanced. Learn about Breast Cancer.
- Childhood Iron Deficiency AnemiaDr. Becker-Koepke isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Colorectal CancerDr. Becker-Koepke isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Becker-Koepke isAdvanced. Learn about Familial Colorectal Cancer.
- Folate DeficiencyDr. Becker-Koepke isAdvanced. Learn about Folate Deficiency.
- Follicular LymphomaDr. Becker-Koepke isAdvanced. Learn about Follicular Lymphoma.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Becker-Koepke isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Acute Mountain SicknessDr. Becker-Koepke isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Becker-Koepke isExperienced. Learn about Adult Immune Thrombocytopenia.
- Adult Soft Tissue SarcomaDr. Becker-Koepke isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Becker-Koepke isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Becker-Koepke isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.